281 related articles for article (PubMed ID: 16200777)
1. [Clinical tolerance test of recombinant human thrombopoietin].
Zhao Y; Jiang J; Jiao L
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1508-11. PubMed ID: 16200777
[TBL] [Abstract][Full Text] [Related]
2. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
[TBL] [Abstract][Full Text] [Related]
3. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
Xu YH; Chen ZW; Ye XY; Lu S
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920
[TBL] [Abstract][Full Text] [Related]
5. Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis.
van de Ven C; Fernandez GW; Herbst T; Knoppel A; Cairo MS
Exp Hematol; 1997 Aug; 25(9):1005-12. PubMed ID: 9257814
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.
Wolff SN; Herzig R; Lynch J; Ericson SG; Greer JP; Stein R; Goodman S; Benyunes MC; Ashby M; Jones DV; Fay J
Bone Marrow Transplant; 2001 Feb; 27(3):261-8. PubMed ID: 11277173
[TBL] [Abstract][Full Text] [Related]
7. [Value of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
Dai XF; Yu J; Liu L; Wu G
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):623-5. PubMed ID: 19102944
[TBL] [Abstract][Full Text] [Related]
8. A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience.
Angiolillo AL; Davenport V; Bonilla MA; van de Ven C; Ayello J; Militano O; Miller LL; Krailo M; Reaman G; Cairo MS;
Clin Cancer Res; 2005 Apr; 11(7):2644-50. PubMed ID: 15814645
[TBL] [Abstract][Full Text] [Related]
9. Importance of predosing of recombinant human thrombopoietin to reduce chemotherapy-induced early thrombocytopenia.
Vadhan-Raj S; Patel S; Bueso-Ramos C; Folloder J; Papadopolous N; Burgess A; Broemeling LD; Broxmeyer HE; Benjamin RS
J Clin Oncol; 2003 Aug; 21(16):3158-67. PubMed ID: 12915607
[TBL] [Abstract][Full Text] [Related]
10. [A multi-center clinical trial of recombinant human thrombopoietin in chronic refractory idiopathic thrombocytopenic purpura].
Zhao YQ; Wang QY; Zhai M; Xu J; Chen XQ; Liu WL; Zhang M; Song SJ; Wang JM; Meng FY; Shan YD
Zhonghua Nei Ke Za Zhi; 2004 Aug; 43(8):608-10. PubMed ID: 15355668
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and peripheral platelet counts after a single dose of recombinant human thrombopoietin in rhesus monkeys.
Song HF; Liu XW; Tang ZM
Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):244-8. PubMed ID: 10452100
[TBL] [Abstract][Full Text] [Related]
12. Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia--a randomized, placebo-controlled, double-blind safety and efficacy study.
Geissler K; Yin JA; Ganser A; Sanz MA; Szer J; Raghavachar A; Hoelzer D; Martinez C; Taylor K; Kanz L; To LB; Archimbaud E
Ann Hematol; 2003 Nov; 82(11):677-83. PubMed ID: 14530872
[TBL] [Abstract][Full Text] [Related]
13. Effect of c-mpl ligands after total body irradiation (TBI) with and without allogeneic hematopoietic stem cell transplantation: low-dose TBI does not prevent sensitization.
Nash RA; Takatu A; Feng Z; Slichter S; Abrams K; Espino G; Gass MJ; Georges GE; McSweeney PA; Shulman HM; Storb R
Biol Blood Marrow Transplant; 2002; 8(7):360-7. PubMed ID: 12171482
[TBL] [Abstract][Full Text] [Related]
14. [Prophylactic recombinant human thrombopoietin treatment alleviates chemotherapy- induced thrombocytopenia in tumor patients].
Li Q; Ye M; Xiao W; Zhu J; Zhang S
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):1064-6. PubMed ID: 22820601
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human thrombopoietin treatment promotes hematopoiesis recovery in patients with severe aplastic anemia receiving immunosuppressive therapy.
Wang H; Dong Q; Fu R; Qu W; Ruan E; Wang G; Liu H; Wu Y; Song J; Xing L; Guan J; Li L; Shao Z
Biomed Res Int; 2015; 2015():597293. PubMed ID: 25861635
[TBL] [Abstract][Full Text] [Related]
16. [Clinical use of recombinant human thrombopoietin. Status and perspectives].
Hansen PB; Hasselbalch HC
Ugeskr Laeger; 2001 May; 163(19):2659-62. PubMed ID: 11360368
[TBL] [Abstract][Full Text] [Related]
17. Clinical studies with megakaryocyte growth and development factor (Mpl-ligand).
Begley CG
Thromb Haemost; 1997 Jul; 78(1):42-6. PubMed ID: 9198125
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human thrombopoietin improves platelet counts and reduces platelet transfusion possibility among patients with severe sepsis and thrombocytopenia: a prospective study.
Wu Q; Ren J; Wu X; Wang G; Gu G; Liu S; Wu Y; Hu D; Zhao Y; Li J
J Crit Care; 2014 Jun; 29(3):362-6. PubMed ID: 24405656
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human thrombopoietin in combination with cyclosporin A as a novel therapy in corticosteroid-resistant primary immune thrombocytopenia.
Cui ZG; Liu XG; Qin P; Hou M; Wu SL; Peng J; Zhao HG; Wang HY; Zhao CT
Chin Med J (Engl); 2013 Nov; 126(21):4145-8. PubMed ID: 24229688
[TBL] [Abstract][Full Text] [Related]
20. A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.
Nash RA; Kurzrock R; DiPersio J; Vose J; Linker C; Maharaj D; Nademanee AP; Negrin R; Nimer S; Shulman H; Ashby M; Jones D; Appelbaum FR; Champlin R
Biol Blood Marrow Transplant; 2000; 6(1):25-34. PubMed ID: 10707996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
